Kothari Petrochemicals Share Price Target 2026, 2027, 2028, 2029, 2030

Kothari Petrochemicals share price today

Kothari Petrochemicals, part of the Chennai-based HC Kothari group, makes polyisobutylene. PIB is a sticky, chemically stable synthetic polymer that ends up in places most people never think about: lubricant additive packages, adhesive and sealant formulations, cling film, cable compounds, fuel additives and chewing-gum base. The company operates from Manali in north Chennai and describes itself as India’s largest PIB producer, selling into roughly twenty countries.

At the 6 August 2026 cut-off the share closed at ₹149.53, a reconciled market capitalisation near ₹880 crore on trailing EPS of ₹12.35. The quote above is live; the figures below are fixed to that session.

This is the cheapest company in this batch by a distance — about 12.1 times earnings and 2.4 times book — and it holds the strongest domestic market position of any of them. It is also the only one where the return on capital has fallen below its own five-year average, which is the honest reason the market is not paying more.

A domestic near-monopoly in an unglamorous polymer

PIB production is a specialised business. The feedstock is a C4 stream — isobutylene derived from refinery and cracker operations — and the process requires low-temperature polymerisation with tight control over molecular weight, because the molecular weight determines the application. Low-molecular-weight grades go into lubricant additives and fuel detergents; higher grades go into adhesives, sealants and rubber compounding.

Structural feature	Position at Kothari	Investment consequence
Domestic competition	Very limited; the company is the scale domestic producer	Pricing power against imports, within limits
Capacity	Reported at roughly 30,000 to 36,000 tonnes a year	Small in global terms; adequate domestically
Feedstock	C4 stream sourced adjacent to refinery operations	Location advantage, but exposure to refinery economics
Product grades	Multiple molecular-weight grades across end uses	Diversifies demand across several cycles
Export reach	Customers in around twenty countries	Absorbs domestic softness; adds currency exposure

Sources differ on the exact nameplate capacity, which is why we have given a range rather than a single figure. The strategic point is unaffected: this is a small plant by global standards and a dominant one in India.

The domestic monopoly is real but bounded. Kothari does not compete with nobody; it competes with imports. That sets a ceiling on realisations equal to landed import cost, and it means global PIB capacity additions and freight rates affect Indian pricing even when no domestic competitor exists.

Why the return on capital has slipped

This is the number that matters most, and it points the opposite way from the rest of this batch.

Return measure	Current	Five-year average	Direction
Return on capital employed	28.60%	32.54%	Below its own average
Return on equity	21.43%	—	Solid but not exceptional
Operating margin	16.43%	—	Modest for a specialty polymer
Five-year sales CAGR	21.12%	—	Genuine volume and price growth
Five-year profit CAGR	26.43%	—	Ahead of sales

Almost every other company in this batch shows current ROCE running above its five-year average — the signature of a favourable cycle. Kothari shows the reverse. Return on capital roughly four points below its own five-year norm is consistent with a period of feedstock cost pressure, weaker spreads, or capital deployed into expansion that has not yet produced proportionate returns.

We think that is exactly why the shares trade at 12 times earnings while comparable-quality small chemical companies trade at twenty or more. The market is pricing a business whose returns are currently compressed, not one whose returns are peaking. For an investor with patience, that is a more comfortable starting point than the reverse, provided the compression is cyclical.

Feedstock is the cycle

The company’s economics are a spread: the gap between the cost of the C4 feedstock and the realised price of PIB. Both ends move.

Cycle input	Favourable conditions	Unfavourable conditions
C4 feedstock cost	Ample refinery supply, soft crude	Tight C4 availability, crude spikes
PIB realisations	Firm global pricing, high freight on imports	Global overcapacity, cheap landed imports
Lubricant demand	Industrial and automotive activity strong	Industrial slowdown, EV transition over the long run
Adhesives and sealants	Construction and packaging growth	Construction slowdown
Currency	Weak rupee helps exports and import parity	Strong rupee compresses both

The lubricant additive exposure deserves one honest long-term note. A meaningful share of PIB demand is tied to engine lubricants, and the very long-run shift toward electric vehicles reduces engine oil consumption. This is a decade-scale consideration rather than a five-year one — industrial lubricants, adhesives, sealants and film applications are unaffected — but it belongs in the risk register of anyone modelling this business to 2030 and beyond.

Q1 FY27 in context

The June 2026 quarter reported sales of about ₹146 crore with net profit near ₹17 crore, an implied net margin around 11.6%.

Q1 FY27 measure	Reported outcome	Reading
Sales	About ₹146 Cr	Roughly ₹584 Cr annualised
Net profit	About ₹17 Cr	Roughly ₹68 Cr annualised
Implied net margin	About 11.6%	Consistent with a 16.43% operating margin
Trailing annual profit	About ₹73 Cr	Implied by ₹12.35 EPS on 5.8857 crore shares

Put those last two rows side by side and the quarter is informative. Annualising the June quarter gives profit slightly below the trailing twelve-month figure, which is consistent with the return-on-capital picture below: this is a business whose earnings are currently flat to mildly compressing, not one accelerating into a recovery. That is not a reason to avoid it at twelve times earnings, but it does mean the bear case is describing the present rather than a hypothetical.

We were not able to source a current quantified update on the debottlenecking and capacity expansion the company has referenced, so that remains a stated intention in the analysis below rather than a modelled contributor.

Valuation at the fixed price

At ₹149.53 the shares traded at about 12.1 times trailing earnings and 2.4 times book, with a dividend yield near 0.67%. The 52-week range ran ₹94.75 to ₹174.00, so the cut-off price sat roughly 14% below the high.

Valuation metric	6 August 2026 value	Basis
Share price	₹149.53	Exchange close on the cut-off date
Reconciled market capitalisation	₹880 Cr	Price times about 5.8857 crore shares
Recalculated P/E	12.11×	₹149.53 divided by trailing EPS of ₹12.35
Recalculated price to book	2.36×	₹149.53 divided by ₹63.30 book value per share
Recalculated PEG	About 0.46	P/E divided by the 26.43% five-year profit CAGR
Dividend yield	About 0.67%	On roughly ₹1.00 per share
52-week range	₹94.75 – ₹174.00	Cut-off price about 14% below the high

Two and a half times book for a business earning 21% on equity and 28.6% on capital is the sort of valuation that only appears when the market expects returns to fall further. That may be right. The point of buying it is the judgement that the compression is a feedstock cycle rather than a permanent change in the competitive position — and the domestic position is the reason to think so.

The valuation fields available were captured on a different day from the price we fixed, so market capitalisation and each per-share ratio were recomputed against the same ₹149.53 close and roughly 5.8857 crore shares.

Valuation framework: a deliberately modest set of multiples

The model compounds trailing EPS of ₹12.35 from the cut-off, applying 147/365 of a year’s growth to the 2026 row and one further full year to each later row, then an exit price-to-earnings multiple. Values round to the nearest ₹5 and exclude dividends.

Scenario	Annual EPS growth	Exit P/E	Operating interpretation
Bear	7%	9×	Feedstock pressure persists, imports cap pricing, the discount widens
Base	12%	13×	Spreads normalise gradually and the multiple stays modest
Bull	17%	17×	Expansion completes, returns recover toward the 32.5% historical level

These are the lowest exit multiples in this batch, and deliberately so. A single-product, single-site petrochemical business with feedstock exposure should not be capitalised at specialty-chemical multiples, even when its domestic position is strong. The bull case at 17 times is roughly where a good cyclical chemical company trades in a favourable year, not a re-rating to premium status.

Kothari Petrochemicals share price target 2026 to 2030

The grid above resolves those assumptions into yearly values. Because the starting multiple is low, this is one of the few tables in this batch where the earnings assumption matters more than the exit multiple.

What would change the thesis

The case strengthens if return on capital recovers toward the 32.5% five-year average, if the debottlenecking is completed and converts into disclosed volume growth, if operating margin moves above 18% as spreads normalise, and if export revenue grows as a share of the mix.

It weakens if C4 feedstock costs stay elevated, if global PIB capacity additions push landed import prices below domestic realisations, if the expansion consumes capital without lifting returns, or if lubricant-linked demand softens faster than adhesive and film applications can replace it.

Quarterly monitoring scorecard

Question	Constructive evidence	Warning sign
Are returns recovering?	ROCE moves back toward 32%	Continued drift below 28%
Is the spread widening?	Operating margin rises above 18%	Compression below 13%
Is volume growing?	Capacity utilisation and tonnage rise	Volume flat while revenue moves on price alone
Is expansion productive?	Debottlenecking adds disclosed output	Capital spent without volume disclosure
Is import pressure manageable?	Realisations hold against landed cost	Domestic pricing follows imports downward
Is the balance sheet intact?	Expansion funded internally, pledge stays zero	Borrowings rise to fund capacity

What to weigh at the current price

The attraction is unusual in this batch: a genuine domestic leader in a niche polymer, earning 28.6% on capital, available at roughly 12 times earnings and 2.4 times book, with the shares 14% below their high and returns already depressed relative to their own history. Most of the risk in the other ten articles here is that you are paying for a good cycle. Here the risk is closer to the opposite.

The reservations are real and should be weighed properly. Returns are falling rather than rising, the feedstock exposure is genuine, the plant is small by global standards, and the June quarter annualises to slightly less profit than the trailing twelve months rather than more. Our view is that the valuation compensates for the cyclicality and that the domestic position is durable, but this is explicitly a case of buying a business whose earnings are flat and whose returns are below their own average, on the judgement that both are cyclical. If that judgement is wrong, twelve times earnings will not prove to be the floor it looks like.

FAQ

What is the Kothari Petrochemicals share price target for 2030?

The grid above gives bear, base and bull values from trailing EPS, a growth assumption and an exit multiple. The exit multiples used are the lowest in this batch, reflecting the cyclical, single-product nature of the business.

What is polyisobutylene used for?

Lubricant additive packages and fuel detergents, adhesives and sealants, cling film and packaging, cable compounds and chewing-gum base, among other applications. Different molecular weights serve different end uses.

Is Kothari Petrochemicals really a monopoly?

It is the scale domestic producer of PIB in India, but it competes with imports. That caps realisations at roughly landed import cost, so the position confers pricing advantage rather than pricing freedom.

Why is the valuation so much lower than similar chemical companies?

Because return on capital is currently running about four points below its own five-year average, the product is a single polymer exposed to feedstock cycles, and the plant is small in global terms.

What is the biggest risk in Kothari Petrochemicals shares?

Feedstock and spread cyclicality. The company earns the gap between C4 input cost and PIB realisations, and both ends are set by markets it does not control. Long term, the shift away from engine lubricants is a slow additional headwind.

When does Kothari Petrochemicals report its next result?

Check the results calendar and confirm the board-meeting date from the company’s own exchange filing before relying on any estimate. The June 2026 quarter is already reported and is summarised above.

Related research

• Vinati Organics share price target
• Epigral share price target
• Navin Fluorine share price target

Sources and methodology

• Kothari Petrochemicals on Screener
• Kothari Petrochemicals company profile
• Kothari Petrochemicals plant details
• Kothari Petrochemicals product range
• Kothari Petrochemicals capacity expansion coverage

Return and margin metrics are Screener figures captured on 6 August 2026, with price and the 52-week range taken from exchange closing data for the same session; per-share ratios were recomputed against that single price. Capacity is given as a range because published sources differ. June-quarter sales and profit were taken from Screener on a later cross-check, after the first draft of this article could find no reliable contemporaneous report; they are quoted to the rounding Screener itself uses. The capacity-expansion programme remains a stated intention because no quantified project update was available.

---

This article is research and education, not personalised investment advice or a recommendation to transact. Gale is not a SEBI-registered investment adviser. Price targets are scenario arithmetic, not promises. Verify current filings, liquidity, corporate actions and suitability, and consult a registered adviser before acting.